Polidocanol
(ONJQDTZCDSESIW-UHFFFAOYSA-N)
Structure
- SMILES
- CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
- Type(s)
- Approved
- ATC code(s)
- C05BB02
- Molecular Formula:
- C30H62O10
- Molecular Weight:
- 582.807
- Log P:
- 4.0490
- Hydrogen Bond Acceptor:
- 10
- Hydrogen Bond Donor:
- 1
- TPSA:
- 103.3
- CAS Number(s):
- 3055-99-0; 9002-92-0; 9043-30-5
Synonym(s)
1.
Polidocanol
2.
Aethoxysclerol
3.
Aethoxysklerol
4.
Aetoxisclerol
5.
Atossisclerol
6.
Atoxysclerol
7.
Brij 30
8.
Brij-30
9.
Dodecyl Ethyleneglycol Monoether
10.
Ethoxysclerol
11.
Hydroxypolyethoxydodecane
12.
Laureth
13.
Laureth 9
14.
Laureth-1
15.
Laureth-4
16.
Laureth-7
17.
Laureth-9
18.
Lauromacrogol
19.
Lauromacrogol 400
20.
Lauromacrogols
21.
Lubrol 12A9
22.
Lubrol-PX
23.
Nonaethylene Glycol Monododecyl Ether
24.
Nonaethyleneglycol Monododecyl Ether
25.
Polyethylene Glycol Monododecyl Ether
26.
Polyethylene Glycol-7-lauryl Ether
27.
Polyoxyethylene 9-lauryl Ether
28.
Polyoxyethylene Lauryl Ether
29.
Polyoxyethylene(4) Lauryl Ether
30.
Polyoxyethylene-4-dodecyl Ether
31.
Polyoxyethylenedodecyl Ether
32.
Tetraethylene Glycol Dodecyl Ether
33.
Tetraethyleneglycol Lauryl Ether
34.
Thesit
35.
alpha-Dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl)
36.
Brij30
37.
Dodecyl Ethyleneglycol Monoethers
38.
Ether, Nonaethyleneglycol Monododecyl
39.
Ether, Polyethylene Glycol-7-lauryl
40.
Ether, Polyoxyethylene 9-lauryl
41.
Ether, Polyoxyethylene Lauryl
42.
Ether, Polyoxyethylene-4-dodecyl
43.
Ether, Tetraethyleneglycol Lauryl
44.
Ethyleneglycol Monoether, Dodecyl
45.
Laureth 1
46.
Laureth 4
47.
Laureth 7
48.
Laureths
49.
Lauryl Ether, Tetraethyleneglycol
50.
Lubrol PX
51.
Monododecyl Ether, Nonaethyleneglycol
52.
Monoether, Dodecyl Ethyleneglycol
53.
Nonaethyleneglycol Monododecyl Ethers
54.
Polidocanols
55.
Polyethylene Glycol 7 lauryl Ether
56.
Polyethylene Glycol-7-lauryl Ethers
57.
Polyoxyethylene 4 dodecyl Ether
58.
Polyoxyethylene 9 lauryl Ether
59.
Polyoxyethylene 9-lauryl Ethers
60.
Polyoxyethylene Lauryl Ethers
61.
Polyoxyethylenedodecyl Ethers
62.
Tetraethyleneglycol Lauryl Ethers
External Link(s)
| MeSH | D000077423 |
| PubChem Compound | 656641 |
| ChEBI | 46859 |
| CHEMBL | CHEMBL1231723 |
| DrugBank | DB06811 |
| KEGG | cpd:C13493 |
| Therapeutic Target Database | D05ZPL |
| ZINC | 8214662 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Deep Vein Thrombosis | FAERS: 60 | US FAERS | |
| 2 | Pain | FAERS: 21 | US FAERS | |
| 3 | Erythema | FAERS: 19 | US FAERS | |
| 4 | Drug ineffective | FAERS: 14 | US FAERS | |
| 5 | Injection site pain | FAERS: 13 | US FAERS | |
| 6 | Swelling | FAERS: 12 | US FAERS | |
| 7 | Phlebitis | FAERS: 10 | US FAERS | |
| 8 | Pruritus | FAERS: 10 | US FAERS | |
| 9 | Urticaria | FAERS: 10 | US FAERS | |
| 10 | Venous thrombosis limb | FAERS: 10 | US FAERS | |
| 11 | Hypersensitivity | FAERS: 9 | US FAERS | |
| 12 | Nausea | FAERS: 9 | US FAERS | |
| 13 | Product quality issue | FAERS: 9 | US FAERS | |
| 14 | No adverse event | FAERS: 8 | US FAERS | |
| 15 | Therapy change | FAERS: 8 | US FAERS | |
| 16 | Headache | FAERS: 7 | US FAERS | |
| 17 | Pulmonary Embolism | FAERS: 7 | US FAERS | |
| 18 | Wrong technique in product usage process | FAERS: 7 | US FAERS | |
| 19 | Dizziness | FAERS: 5 | US FAERS | |
| 20 | Dysgeusia | FAERS: 5 | US FAERS | |
| 21 | Injection site urticaria | FAERS: 5 | US FAERS | |
| 22 | Asthenia | FAERS: 4 | US FAERS | |
| 23 | Chest Pain | FAERS: 4 | US FAERS | |
| 24 | Drug administration error | FAERS: 4 | US FAERS | |
| 25 | Fatigue | FAERS: 4 | US FAERS | |
| 26 | Injection site warmth | FAERS: 4 | US FAERS | |
| 27 | Malaise | FAERS: 4 | US FAERS | |
| 28 | Palpitations | FAERS: 4 | US FAERS | |
| 29 | Peripheral swelling | FAERS: 4 | US FAERS | |
| 30 | Poor quality drug administered | FAERS: 4 | US FAERS | |
| 31 | Product availability issue | FAERS: 4 | US FAERS | |
| 32 | Product preparation error | FAERS: 4 | US FAERS | |
| 33 | Skin necrosis | FAERS: 4 | US FAERS | |
| 34 | Thrombosis | FAERS: 4 | US FAERS | |
| 35 | Burning sensation | FAERS: 3 | US FAERS | |
| 36 | Feeling abnormal | FAERS: 3 | US FAERS | |
| 37 | Flushing | FAERS: 3 | US FAERS | |
| 38 | Hypokinesia | FAERS: 3 | US FAERS | |
| 39 | Hypotension | FAERS: 3 | US FAERS | |
| 40 | Injection site erythema | FAERS: 3 | US FAERS | |
| 41 | Injection site necrosis | FAERS: 3 | US FAERS | |
| 42 | Limb discomfort | FAERS: 3 | US FAERS | |
| 43 | Necrosis | FAERS: 3 | US FAERS | |
| 44 | Nodule | FAERS: 3 | US FAERS | |
| 45 | Skin reaction | FAERS: 3 | US FAERS | |
| 46 | Ulcer | FAERS: 3 | US FAERS | |
| 47 | Vomiting | FAERS: 3 | US FAERS | |
| 48 | Accidental exposure to product | FAERS: 2 | US FAERS | |
| 49 | Cellulitis | FAERS: 2 | US FAERS | |
| 50 | Chest discomfort | FAERS: 2 | US FAERS | |
| 51 | Chills | FAERS: 2 | US FAERS | |
| 52 | Dermatitis | FAERS: 2 | US FAERS | |
| 53 | Dyspepsia | FAERS: 2 | US FAERS | |
| 54 | Ecchymosis | FAERS: 2 | US FAERS | |
| 55 | Expired product administered | FAERS: 2 | US FAERS | |
| 56 | Extravasation | FAERS: 2 | US FAERS | |
| 57 | Infusion site thrombosis | FAERS: 2 | US FAERS | |
| 58 | Injection site bruising | FAERS: 2 | US FAERS | |
| 59 | Intercepted medication error | FAERS: 2 | US FAERS | |
| 60 | Myocardial Infarction | FAERS: 2 | US FAERS | |
| 61 | Oropharyngeal discomfort | FAERS: 2 | US FAERS | |
| 62 | Pain of skin | FAERS: 2 | US FAERS | |
| 63 | Peripheral embolism | FAERS: 2 | US FAERS | |
| 64 | Phlebitis deep | FAERS: 2 | US FAERS | |
| 65 | Pneumonia | FAERS: 2 | US FAERS | |
| 66 | Presyncope | FAERS: 2 | US FAERS | |
| 67 | Scab | FAERS: 2 | US FAERS | |
| 68 | Skin Ulcer | FAERS: 2 | US FAERS | |
| 69 | Thrombophlebitis | FAERS: 2 | US FAERS | |
| 70 | skin abrasion | FAERS: 2 | US FAERS | |
| 71 | Abasia | FAERS: 1 | US FAERS | |
| 72 | Acute Coronary Syndrome | FAERS: 1 | US FAERS | |
| 73 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 74 | Administration site swelling | FAERS: 1 | US FAERS | |
| 75 | Agitation | FAERS: 1 | US FAERS | |
| 76 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 77 | Amnesia | FAERS: 1 | US FAERS | |
| 78 | Amputation | FAERS: 1 | US FAERS | |
| 79 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 80 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 81 | Angioedema | FAERS: 1 | US FAERS | |
| 82 | Aphasia | FAERS: 1 | US FAERS | |
| 83 | Application site erythema | FAERS: 1 | US FAERS | |
| 84 | Application site pain | FAERS: 1 | US FAERS | |
| 85 | Arterial thrombosis | FAERS: 1 | US FAERS | |
| 86 | Bone pain | FAERS: 1 | US FAERS | |
| 87 | Bowel movement irregularity | FAERS: 1 | US FAERS | |
| 88 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 89 | Cyanosis | FAERS: 1 | US FAERS | |
| 90 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 91 | Discomfort | FAERS: 1 | US FAERS | |
| 92 | Drug administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 93 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 94 | Dysarthria | FAERS: 1 | US FAERS | |
| 95 | Electrocardiogram ST-T segment depression | FAERS: 1 | US FAERS | |
| 96 | Embolism | FAERS: 1 | US FAERS | |
| 97 | Epidermal necrosis | FAERS: 1 | US FAERS | |
| 98 | Epistaxis | FAERS: 1 | US FAERS | |
| 99 | Facial paralysis | FAERS: 1 | US FAERS | |
| 100 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 101 | Granuloma Annulare | FAERS: 1 | US FAERS | |
| 102 | Hemiparesis | FAERS: 1 | US FAERS | |
| 103 | Hemiplegia | FAERS: 1 | US FAERS | |
| 104 | Hypersomnia | FAERS: 1 | US FAERS | |
| 105 | Hypoxia | FAERS: 1 | US FAERS | |
| 106 | Inadequate aseptic technique in use of product | FAERS: 1 | US FAERS | |
| 107 | Incoherent | FAERS: 1 | US FAERS | |
| 108 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 109 | Induration | FAERS: 1 | US FAERS | |
| 110 | Infection | FAERS: 1 | US FAERS | |
| 111 | Inflammation | FAERS: 1 | US FAERS | |
| 112 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 113 | Injection site discomfort | FAERS: 1 | US FAERS | |
| 114 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 115 | Injection site irritation | FAERS: 1 | US FAERS | |
| 116 | Injection site thrombosis | FAERS: 1 | US FAERS | |
| 117 | Injection site ulcer | FAERS: 1 | US FAERS | |
| 118 | Injection site vesicles | FAERS: 1 | US FAERS | |
| 119 | Intercepted drug administration error | FAERS: 1 | US FAERS | |
| 120 | Mastitis | FAERS: 1 | US FAERS | |
| 121 | Medical device site vesicles | FAERS: 1 | US FAERS | |
| 122 | Migraine with Aura | FAERS: 1 | US FAERS | |
| 123 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 124 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 125 | Neuralgia | FAERS: 1 | US FAERS | |
| 126 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 127 | Pallor | FAERS: 1 | US FAERS | |
| 128 | Pancreatitis | FAERS: 1 | US FAERS | |
| 129 | Peripheral venous disease | FAERS: 1 | US FAERS | |
| 130 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 131 | Proteinuria | FAERS: 1 | US FAERS | |
| 132 | Pulmonary Infarction | FAERS: 1 | US FAERS | |
| 133 | Purpura | FAERS: 1 | US FAERS | |
| 134 | Rash erythematous | FAERS: 1 | US FAERS | |
| 135 | Respiratory distress | FAERS: 1 | US FAERS | |
| 136 | Right Ventricular Dysfunction | FAERS: 1 | US FAERS | |
| 137 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 138 | Skin lesion | FAERS: 1 | US FAERS | |
| 139 | Soft tissue necrosis | FAERS: 1 | US FAERS | |
| 140 | Somnolence | FAERS: 1 | US FAERS | |
| 141 | Splenic Infarction | FAERS: 1 | US FAERS | |
| 142 | Swelling of eyelid | FAERS: 1 | US FAERS | |
| 143 | Tachycardia | FAERS: 1 | US FAERS | |
| 144 | Temperature difference of extremities | FAERS: 1 | US FAERS | |
| 145 | Thermal burn | FAERS: 1 | US FAERS | |
| 146 | Tinnitus | FAERS: 1 | US FAERS | |
| 147 | Tremor | FAERS: 1 | US FAERS | |
| 148 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 149 | Visual Impairment | FAERS: 1 | US FAERS | |
| 150 | Weight decreased | FAERS: 1 | US FAERS | |
| 151 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 152 | Xanthopsia | FAERS: 1 | US FAERS | |
| 153 | Dermatitis, Allergic Contact | 11846753 | CTD | |
| 154 | Facial Dermatoses | 11846753 | CTD | |
| 155 | Hand Dermatoses | 11846753 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.